FDA to Monitor Post-Market Drug Safety
Forbes - NY,USA
Another drug, the multiple sclerosis medication Tysabri,
was pulled from pharmacy shelves in early 2005 after
several patients in clinical trials developed ...

Health Advances strengthens management team
Consultant News - UK
... was responsible for developing and executing the US
commercial strategies for Avonex(R) and Tysabri(R),
two leading therapies for multiple sclerosis. ...

Wachovia health care conference opens in Boston
Boston Globe - Boston,MA,USA
Biogen Idec Inc. will get a chance to update investors on
its relaunch of multiple sclerosis treatment Tysabri,
which was taken off the market about two ...
See all stories on this topic

Opexa Achieves Midpoint in Patient Admissions in Phase IIb Trial ...
Business Wire (press release) - San Francisco,CA,USA
David McWilliams, president and chief executive officer of Opexa,
commented, “Given the efficacy and safety demonstrated in our
Phase I/II study of Tovaxin ...

Market Report -- In Play (WIRES)
MSN Money - USA
Opexa Therapeutics (OPXA) announces that it has admitted
the first 75 patients in its 150-patient Phase IIb clinical trial
of Tovaxin in multiple sclerosis. ...

Family Members With Multiple Sclerosis Likely To Share Onset Age, But Not Disease Severity Science Daily Tue, 30 Jan 2007 3:09 AM PST When more than one member of a family is affected by multiple sclerosis (MS), their ages at disease onset are likely to be similar, but disease severity may not be. These new findings have important implications for counseling patients, according to a study published in the January 30, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

Opexa Achieves Midpoint in Patient Admissions in Phase IIb Trial of Tovaxin(TM) for Multiple Sclerosis RedNova Tue, 30 Jan 2007 8:17 AM PST Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company involved in the development and commercialization of cell therapies, announced today that it has admitted the first 75 patients in its 150-patient Phase IIb clinical trial of Tovaxin™ in multiple sclerosis.

Carbon Monoxide Protects Mice From Multiple Sclerosis Medical News Today Tue, 30 Jan 2007 4:01 AM PST Multiple sclerosis (MS) is a chronic inflammatory disorder that causes degeneration of the nerves in the brain and spinal cord, leading to various symptoms including muscle weakness and pain. Most individuals with MS go through cycles of disease and remission, leading to the suggestion that there are regulatory mechanisms that counter the disease-causing inflammation. [click link for full article]

Multiple Sclerosis Rates Up 50% WebMD Mon, 29 Jan 2007 1:21 PM PST Multiple sclerosis (MS) may be 50% more common in the U.S. than previously thought, according to a new research review.

Multiple sclerosis far more common than previously thought News-Medical-Net Mon, 29 Jan 2007 8:13 PM PST A new review of hundreds of research articles has shown that the prevalence of multiple sclerosis (MS) is far higher than previously thought amongst the U.S. population.

Families with multiple sclerosis show similar age patterns CBC Mon, 29 Jan 2007 1:18 PM PST Family members with multiple sclerosis are likely to develop the disease at similar ages, but the severity may differ, new research suggests.

Neurological disease common, survey finds Reuters via Yahoo! News Tue, 30 Jan 2007 6:06 AM PST Multiple sclerosis, Parkinson's disease and other neurological diseases may be far more common than most people had believed, according to new estimates published on Monday.

Familial Factors May Not Impact MS Severity: Study HealthCentral.com Mon, 29 Jan 2007 3:22 PM PST MONDAY, Jan. 29 (HealthDay News) -- In families where more than one person has multiple sclerosis (MS), people are likely to experience the onset of MS at a similar age, but they may not have similar disease severity, a U.K. study finds.

Family members with MS likely to share onset age, but not disease severity EurekAlert! Mon, 29 Jan 2007 1:12 PM PST ST. PAUL, Minn -- When more than one member of a family is affected by multiple sclerosis (MS), their ages at disease onset are likely to be similar, but disease severity may not be.

Marked rise in MS in the US debated by scientists
New Scientist Mon, 29 Jan 2007 1:33 PM PST
An review of recent studies suggests that 1 out of every 1000 people in the US suffers from multiple sclerosis – a 50% climb in just 25 years